Alexander Dressel
Heidelberg University
17 Papers
69 Citations
Alexander Dressel is an academic researcher from Heidelberg University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 10, co-authored 17 publications.
Chat about Author
Papers
Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk.
Stephen Zewinger,Christiane Drechsler,Marcus E. Kleber,Alexander Dressel,Julia Riffel,Sarah Triem,Marlene Lehmann,Chantal Kopecky,Marcus D. Säemann,Philipp M. Lepper,Günther Silbernagel,Hubert Scharnagl,Andreas Ritsch,Barbara Thorand,Tonia de las Heras Gala,Stefan Wagenpfeil,Wolfgang Koenig,Wolfgang Koenig,Annette Peters,Ulrich Laufs,Christoph Wanner,Danilo Fliser,Thimoteus Speer,Winfried März,Winfried März,Winfried März +25 more
TL;DR: The acute-phase protein SAA modifies the biological effects of HDL-C in several clinical conditions, and the concomitant measurement of SAA is a simple, useful, and clinically applicable surrogate for the vascular functionality of HDL.
Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease.
Dan Lindholm,Johan Lindbäck,Paul W. Armstrong,Andrzej Budaj,Christopher P. Cannon,Christopher B. Granger,Emil Hagström,Claes Held,Wolfgang Koenig,Ollie Östlund,Ralph A.H. Stewart,Joseph Soffer,Harvey D. White,Robbert J. de Winter,Philippe Gabriel Steg,Agneta Siegbahn,Marcus E. Kleber,Alexander Dressel,Tanja B. Grammer,Winfried März,Lars Wallentin +20 more
TL;DR: This model provided a robust tool for the prediction of CV death in patients with stable CHD and can be widely employed to complement clinical assessment and guide management based on CV risk.
126
Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry.
Nina Schmidt,Alexander Dressel,Tanja B. Grammer,Ioanna Gouni-Berthold,Ulrich Julius,Ursula Kassner,Gerald Klose,Christel König,Wolfgang Koenig,Britta Otte,Klaus G. Parhofer,Wibke Reinhard,Ulrike Schatz,Heribert Schunkert,Elisabeth Steinhagen-Thiessen,Anja Vogt,Ulrich Laufs,Winfried März +17 more
TL;DR: PCSK9i treatment in addition to standard therapy allows attainment of target values in many patients with initially very high LDL-C, as well as in patients with pre-existing CVD.
32
Iron Metabolism, Hepcidin, and Mortality (the Ludwigshafen Risk and Cardiovascular Health Study)
Tanja B. Grammer,Hubert Scharnagl,Alexander Dressel,Marcus E. Kleber,Günther Silbernagel,Günther Silbernagel,Stefan Pilz,Andreas Tomaschitz,Wolfgang Koenig,Bertram Mueller-Myhsok,Bertram Mueller-Myhsok,Winfried März,Winfried März,Winfried März,Pavel Strnad +14 more
TL;DR: In stable patients undergoing angiography, serum iron, transferrin saturation, sTfR, and ferritin had J-shaped associations and hemoglobin only a marginal association with cardiovascular and total mortality.
30
Cardiovascular risk algorithms in primary care: Results from the DETECT study
Tanja B. Grammer,Alexander Dressel,Ingrid Gergei,Marcus E. Kleber,Ulrich Laufs,Hubert Scharnagl,Uwe Nixdorff,Jens Klotsche,L. Pieper,David Pittrow,Sigmund Silber,Hans-Ulrich Wittchen,Hans-Ulrich Wittchen,Winfried März,Winfried März,Winfried März +15 more
TL;DR: Due to the most precise calibration over a wide range of risks, the large age range covered and the combined endpoint including non-fatal and fatal events, the ASCVD equation provides valid risk prediction for primary prevention in Germany.